Jove
Visualize
Contact Us

Related Experiment Videos

Alpha 2 agonists and antagonists.

R R Paddleford1, R C Harvey

  • 1Department of Small Animal Clinical Science, University of Tennessee, College of Veterinary Medicine, Knoxville, USA. paddleford.robert@hospital.vet.utk.edu

The Veterinary Clinics of North America. Small Animal Practice
|May 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.

Leukemia·2016
Same author

Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk: A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.

Leukemia·2016
Same author

VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.

Leukemia·2013
Same author

Predictors of early mortality among hospitalized nursing home residents.

QJM : monthly journal of the Association of Physicians·2012
Same author

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

Leukemia·2011
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Challenging Gram-negative Infections: Perspectives from a Clinician and a Microbiologist.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Low-dose alpha 2 agonists, combined with opioids and benzodiazepines, offer synergistic sedation and analgesia while minimizing side effects. Reversal agents provide flexibility for veterinarians, enhancing patient safety.

Area of Science:

  • Veterinary Anesthesiology
  • Pharmacology

Background:

  • Alpha 2 agonists provide dose-dependent sedation and analgesia in animals.
  • Adverse physiological effects can occur, influenced by dose, administration, and concurrent drug use.

Purpose of the Study:

  • To evaluate the use of low-dose alpha 2 agonists as preanesthetic agents.
  • To explore the synergistic effects and safety of combining alpha 2 agonists with opioids and benzodiazepines.

Main Methods:

  • Utilizing low doses of alpha 2 agonists, opioids, and benzodiazepines concurrently.
  • Assessing the synergistic central nervous system depressant response.
  • Evaluating the availability and use of specific drug antagonists for reversal.

Main Results:

Related Experiment Videos

  • Combination therapy results in a synergistic CNS depressant effect.
  • Undesirable side effects are minimized compared to higher doses or single agents.
  • Specific antagonists allow for targeted reversal of individual drug classes.

Conclusions:

  • Low-dose alpha 2 agonists are best suited for young, healthy patients as preanesthetics.
  • Combining alpha 2 agonists with opioids and benzodiazepines offers enhanced safety and efficacy.
  • The availability of antagonists provides a significant advantage for managing anesthetic depth and recovery.